/the-u-s-fda-completed-pre-license-inspection-pli-of-wuxi-biologics-cgmp-manufacturing-facilities-for-production-of-tmb-355-ibalizumab/ 鎻愪緵绔埌绔竴绔欏紡瑙ｅ喅鏂规 Wed, 14 Jul 2021 07:36:46 +0000 hourly 1